Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients

NCT00698399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-02-28

No results posted yet for this study

Summary

This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.

Conditions

  • Liver Transplant

Sponsors & Collaborators

Principal Investigators

  • Jeffrey M Waldman, M.D. · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-02-02
Completion
2010-02-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00698399 on ClinicalTrials.gov